According to the latest data, by 2012, the number of new tumors in the world has reached 14 million, and by 2020, it will reach 24 million. The fear of tumors is getting stronger and stronger in people’s mind. But how can we prolong the survival time of tumor patients? That is definitely early diagnosis and early treatment to achieve complete remission in order to improve the long-term survival of tumor. The Centers for Disease Control and Prevention (CDC) released that two out of three patients diagnosed with invasive cancers in the United States survive for more than 5 years, and the most commonly diagnosed cancers have the best survival, with 97% of prostate cancer patients surviving for more than 5 years, followed by breast cancer with 88% of patients surviving at 5 years, and colorectal cancer with 63% of patients surviving at 5 years. The outlook for the very common lung cancer is less promising, with only 18 percent of patients still alive at 5 years. This is the first time the CDC has reported survival data, and it will do so annually, the CDC said in a statement. The results were published in the latest issue of the Morbidity andMortality Weekly Report. The results of this analysis were derived from data from the CDC’s National Cancer Registry program. The authors reviewed recent data, primarily for invasive cancers (limited to cancer spread to surrounding normal tissue, with the exception of bladder cancer). The report also included data on cancer incidence, with the most common sites of cancer occurring as follows: prostate cancer (128 per 100,000 men), breast cancer (122 per 100,000 women), lung and bronchial cancer (61 per 100,000), and colorectal cancer (40 per 100,000). These four sites accounted for about half of all cancers diagnosed in 2011. Cancer incidence rates continue to vary, with men having higher cancer rates than women and blacks having the highest cancer rates. Relative survival at 5 years after cancer diagnosis is lower for blacks than for whites (60% and 65%, respectively). Data from the states also show geographic differences in cancer rates, with 374 per 100,000 people in New Mexico compared to 509 in the District of Columbia. Dr. Lisa Richardson, director of the CDC’s Division of Cancer Prevention and Control, said the data are an important reminder that the key to surviving cancer is to ensure that everyone has access to early diagnosis and treatment.